Ikarian Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.68M | Buy |
449,087
+280,000
| +166% | +$4.79M | 1.48% | 13 |
|
|
2025
Q1 | $10.8M | Buy |
169,087
+135,000
| +396% | +$8.62M | 1.33% | 4 |
|
|
2024
Q4 | $4.14M | Sell |
34,087
-20,089
| -37% | -$2.44M | 0.56% | 26 |
|
|
2024
Q3 | $6.77M | Sell |
54,176
-149,436
| -73% | -$18.7M | 0.94% | 16 |
|
|
2024
Q2 | $32.2M | Buy |
203,612
+51,334
| +34% | +$8.11M | 5.6% | 1 |
|
|
2024
Q1 | $19.7M | Buy |
152,278
+19,638
| +15% | +$2.54M | 2.16% | 5 |
|
|
2023
Q4 | $12.8M | Buy |
+132,640
| New | +$12.8M | 1.2% | 9 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 116 |
|
|
2023
Q2 | – | Sell |
-8,324
| Closed | -$1.15M | – | 113 |
|
|
2023
Q1 | $1.15M | Sell |
8,324
-20,000
| -71% | -$2.76M | 0.26% | 47 |
|
|
2022
Q4 | $3.67M | Buy |
28,324
+11,515
| +69% | +$1.49M | 0.89% | 25 |
|
|
2022
Q3 | $1.86M | Sell |
16,809
-8,191
| -33% | -$905K | 0.37% | 30 |
|
|
2022
Q2 | $1.87M | Buy |
+25,000
| New | +$1.87M | 0.34% | 31 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 175 |
|
|
2021
Q4 | – | Sell |
-6,496
| Closed | -$602K | – | 181 |
|
|
2021
Q3 | $602K | Buy |
+6,496
| New | +$602K | 0.04% | 115 |
|
|
2021
Q2 | – | Sell |
-134
| Closed | -$10K | – | 218 |
|
|
2021
Q1 | $10K | Buy |
+134
| New | +$10K | ﹤0.01% | 176 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 180 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 148 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 130 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 110 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 74 |
|